Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3343587
Max Phase: Preclinical
Molecular Formula: C38H38N5O11PS2
Molecular Weight: 835.85
Molecule Type: Small molecule
Associated Items:
ID: ALA3343587
Max Phase: Preclinical
Molecular Formula: C38H38N5O11PS2
Molecular Weight: 835.85
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(OCC(c3ccccc3)S(=O)(=O)c3ccccc3)OCC(c3ccccc3)S(=O)(=O)c3ccccc3)O2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C38H38N5O11PS2/c1-27-23-43(38(45)40-37(27)44)36-22-32(41-42-39)33(54-36)24-51-55(46,52-25-34(28-14-6-2-7-15-28)56(47,48)30-18-10-4-11-19-30)53-26-35(29-16-8-3-9-17-29)57(49,50)31-20-12-5-13-21-31/h2-21,23,32-36H,22,24-26H2,1H3,(H,40,44,45)/t32-,33+,34?,35?,36+,55?/m0/s1
Standard InChI Key: JIFZVHJFXHETEF-IPEWHYDHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 835.85 | Molecular Weight (Monoisotopic): 835.1747 | AlogP: 6.40 | #Rotatable Bonds: 17 |
Polar Surface Area: 225.89 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 1 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.96 | CX Basic pKa: | CX LogP: 5.79 | CX LogD: 5.68 |
Aromatic Rings: 5 | Heavy Atoms: 57 | QED Weighted: 0.05 | Np Likeness Score: 0.02 |
1. Wang J, Wang YJ, Chen ZS, Kwon CH.. (2014) Synthesis and evaluation of sulfonylethyl-containing phosphotriesters of 3'-azido-3'-deoxythymidine as anticancer prodrugs., 22 (21): [PMID:25440502] [10.1016/j.bmc.2014.09.046] |
Source(1):